Currently, the only established therapeutic option for end-stage liver disease is orthotopic liver transplantation. However, the paucity of donor organs limits this option to only a few patients. From liver stem cells to advanced tissue bioengineering, this episode of EASL Studio discusses regenerative hepatology techniques as an alternative treatment for patients.FacultyProf. Pedro Baptista (Moderator)Prof. Tobias Cantz (Faculty)Prof. Karen Piper Hanley (Faculty)Prof. Frederic Lemaigre (Faculty)Related episode:YI Choice: Propelling liver cell biology into the third dimensionAll EASL Studio Podcasts are available on EASL Campus.